文献
J-GLOBAL ID:201302223229220091
整理番号:13A0640871
クロストリジウム・ディフィシル菌感染症治療用の新たなリポペプチド抗生物質CB-183,315のin vitroおよびin vivo特性
In Vitro and In Vivo Characterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
著者 (10件):
MASCIO Carmela T. M.
(Cubist Pharmaceuticals, Inc., Massachusetts, USA)
,
MORTIN Lawrence I.
(Cubist Pharmaceuticals, Inc., Massachusetts, USA)
,
HOWLAND Karen T.
(Cubist Pharmaceuticals, Inc., Massachusetts, USA)
,
VAN PRAAGH Andrew D. G.
(Cubist Pharmaceuticals, Inc., Massachusetts, USA)
,
ZHANG Shuxin
(Cubist Pharmaceuticals, Inc., Massachusetts, USA)
,
ARYA Anu
(Cubist Pharmaceuticals, Inc., Massachusetts, USA)
,
CHUONG Cun Lan
(Cubist Pharmaceuticals, Inc., Massachusetts, USA)
,
KANG Chunfeng
(Cubist Pharmaceuticals, Inc., Massachusetts, USA)
,
LI Tongchuan
(Cubist Pharmaceuticals, Inc., Massachusetts, USA)
,
SILVERMAN Jared A.
(Cubist Pharmaceuticals, Inc., Massachusetts, USA)
資料名:
Antimicrobial Agents and Chemotherapy
(Antimicrobial Agents and Chemotherapy)
巻:
56
号:
10
ページ:
5023-5030
発行年:
2012年10月
JST資料番号:
E0802A
ISSN:
0066-4804
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)